Literature DB >> 27125674

CD28 and PTPN22 are associated with susceptibility to rheumatoid arthritis in Egyptians.

Mohsen M Hegab1, Aml Fawzy Abdelwahab2, Ali M El-Sayed Yousef3, Mohamed Nabil Salem4, Walaa El-Baz5, Sherry Abdelrhman3, Fatemah Elshabacy3, Abdelazim Alhefny6, Wagida Abouraya5, Saleh Mohamed Ibrahim7, Gaafar Ragab8, Janine Mia Rudolph.   

Abstract

OBJECTIVE: Limited data are available on the genetics of rheumatoid arthritis (RA) in Egyptians. Therefore, we investigated whether the confirmed genetic risk factors for RA in Europeans and/or Asians contribute to RA susceptibility in Egyptians. SUBJECTS AND METHODS: A set of seven single-nucleotide polymorphisms (SNPs) in the vicinity of CD28, TNFAIP3, PTPN22, PADI4 and HLA-DRA were tested in a large multi-centric RA cohort in Egypt, consisting of 394 cases and 398 matched controls. Patients were stratified based on the positivity of either anti-citrullinated protein antibodies (ACPAs) or rheumatoid factor (RF).
RESULTS: Significant association was evident for three SNPs in this cohort: the CD28 (rs1980422) variant showed a strong association in the whole cohort (P=0.000119) and in seropositive subsets of the disease (PACPA+=0.004; PRF+=0.0005). Upon stratification, the PTPN22 (rs2476601) and TNFAIP3(rs5029939) variants showed association only with ACPA positive (PACPA+=0.00573) and negative (PACPA-=0.00999) phenotypes, respectively.
CONCLUSION: Our results suggest that CD28(rs1980422) and PTPN22(rs2476601) contribute to RA-susceptibility in Egyptians. Failure to replicate the association of PADI4(rs2240340)/(PADI4_94) in Egyptian RA patients provides further support for the notion that genetic architecture of RA is different in multiple populations of European, Asian, African, and Middle Eastern ancestries. Further investigation using large-scale studies is thus needed to maximize the power of genetic association.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  ACPAs; Egyptians; RF; Rheumatoid arthritis; SNPs

Mesh:

Substances:

Year:  2016        PMID: 27125674     DOI: 10.1016/j.humimm.2016.04.018

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

Review 1.  Rheumatology in Egypt: back to the future.

Authors:  Tamer A Gheita; Nahla N Eesa
Journal:  Rheumatol Int       Date:  2018-11-07       Impact factor: 2.631

Review 2.  The relationship of PADI4_94 polymorphisms with the morbidity of rheumatoid arthritis in Caucasian and Asian populations: a meta-analysis and system review.

Authors:  Chao Lu; Ke Xu; Hao Guo; Kan Peng; Zhi Yang; Yang Quan Hao; Peng Xu
Journal:  Clin Rheumatol       Date:  2018-01-04       Impact factor: 2.980

3.  Three single nucleotide polymorphisms of TNFAIP3 gene increase the risk of rheumatoid arthritis.

Authors:  Nan Shen; Yuan Ruan; Yajun Lu; Xuefeng Jiang; Huiqing Sun; Gongming Gao; Luming Nong; Kewei Ren
Journal:  Oncotarget       Date:  2017-03-28

Review 4.  TNFAIP3 gene rs10499194, rs13207033 polymorphisms decrease the risk of rheumatoid arthritis.

Authors:  Ming-Jie Wang; Hao-Yu Yang; Hui Zhang; Xindie Zhou; Rui-Ping Liu; Yuan-Yuan Mi
Journal:  Oncotarget       Date:  2016-12-13

5.  Immune Checkpoint-Related Gene Polymorphisms Are Associated With Primary Immune Thrombocytopenia.

Authors:  Shuwen Wang; Xiaoyu Zhang; Shaoqiu Leng; Qirui Xu; Zi Sheng; Yanqi Zhang; Jie Yu; Qi Feng; Ming Hou; Jun Peng; Xiang Hu
Journal:  Front Immunol       Date:  2021-01-05       Impact factor: 7.561

6.  An Autoimmune Disease-Associated Risk Variant in the TNFAIP3 Gene Plays a Protective Role in Brucellosis That Is Mediated by the NF-κB Signaling Pathway.

Authors:  Lixin Lou; Wanguo Bao; Xianjun Liu; Hongxiao Song; Yang Wang; Kaiyu Zhang; Wenjing Gao; Haijun Li; Zhengkun Tu; Shaofeng Wang
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

Review 7.  Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: A systematic review and meta-analysis.

Authors:  Mohammad Javad Mousavi; Mohammad Reza Hooshangi Shayesteh; Sirous Jamalzehi; Reza Alimohammadi; Arezou Rahimi; Saeed Aslani; Nima Rezaei
Journal:  J Res Med Sci       Date:  2021-03-31       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.